300972 Stock Overview
Fujian Wanchen Biotechnology Co., Ltd engages in the research and development, cultivation, production, and sale of edible fungi in China.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 6/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Fujian Wanchen Biotechnology Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥25.07 |
| 52 Week High | CN¥47.53 |
| 52 Week Low | CN¥25.00 |
| Beta | 0.082 |
| 1 Month Change | -20.84% |
| 3 Month Change | -27.21% |
| 1 Year Change | -35.88% |
| 3 Year Change | 9.00% |
| 5 Year Change | n/a |
| Change since IPO | -8.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| 300972 | CN Food | CN Market | |
|---|---|---|---|
| 7D | -5.8% | -2.5% | -0.2% |
| 1Y | -35.9% | -23.1% | -17.8% |
Return vs Industry: 300972 underperformed the CN Food industry which returned -23.1% over the past year.
Return vs Market: 300972 underperformed the CN Market which returned -17.8% over the past year.
Price Volatility
| 300972 volatility | |
|---|---|
| 300972 Average Weekly Movement | 7.4% |
| Food Industry Average Movement | 7.2% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 300972's share price has been volatile over the past 3 months.
Volatility Over Time: 300972's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 1,670 | Li Qing Wang | www.vanchen.com |
Fujian Wanchen Biotechnology Co., Ltd engages in the research and development, cultivation, production, and sale of edible fungi in China. It offers flammulina velutipes; and crab-flavored, white jade, seafood mushrooms, etc. The company was founded in 2011 and is based in Zhangpu, China.
Fujian Wanchen Biotechnology Group Co., Ltd. Fundamentals Summary
| 300972 fundamental statistics | |
|---|---|
| Market cap | CN¥4.56b |
| Earnings (TTM) | -CN¥46.33m |
| Revenue (TTM) | CN¥5.09b |
0.8x
P/S Ratio-93.3x
P/E RatioIs 300972 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300972 income statement (TTM) | |
|---|---|
| Revenue | CN¥5.09b |
| Cost of Revenue | CN¥4.65b |
| Gross Profit | CN¥441.09m |
| Other Expenses | CN¥487.41m |
| Earnings | -CN¥46.33m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 23, 2024
| Earnings per share (EPS) | -0.27 |
| Gross Margin | 8.66% |
| Net Profit Margin | -0.91% |
| Debt/Equity Ratio | 106.0% |
How did 300972 perform over the long term?
See historical performance and comparison